Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 16
1964 22
1965 13
1966 18
1967 24
1968 13
1969 39
1970 38
1971 58
1972 50
1973 46
1974 77
1975 73
1976 80
1977 80
1978 127
1979 114
1980 105
1981 99
1982 105
1983 134
1984 148
1985 150
1986 185
1987 226
1988 333
1989 443
1990 574
1991 538
1992 632
1993 622
1994 793
1995 761
1996 867
1997 882
1998 999
1999 1014
2000 1257
2001 1252
2002 1276
2003 1457
2004 1487
2005 1500
2006 1515
2007 1813
2008 1685
2009 1570
2010 1860
2011 1819
2012 1826
2013 1989
2014 1931
2015 2039
2016 2121
2017 2166
2018 1926
2019 1785
2020 2181
2021 2353
2022 2477
2023 2407
2024 934

Text availability

Article attribute

Article type

Publication date

Search Results

50,735 results

Results by year

Filters applied: . Clear all
Page 1
Treatment of breast cancer.
Maughan KL, Lutterbie MA, Ham PS. Maughan KL, et al. Am Fam Physician. 2010 Jun 1;81(11):1339-46. Am Fam Physician. 2010. PMID: 20521754 Free article. Review.
Stages I and II breast cancers are usually treated with breast-conserving surgery and radiation therapy. ...Anthracycline- and taxane-containing chemotherapeutic regimens are active against breast cancer. Stage III breast cancer typically requires indu …
Stages I and II breast cancers are usually treated with breast-conserving surgery and radiation therapy. ...Anthracycline- and …
Luminal A Breast Cancer and Molecular Assays: A Review.
Gao JJ, Swain SM. Gao JJ, et al. Oncologist. 2018 May;23(5):556-565. doi: 10.1634/theoncologist.2017-0535. Epub 2018 Feb 22. Oncologist. 2018. PMID: 29472313 Free PMC article. Review.
The discovery of different intrinsic subtypes of breast cancer has advanced the understanding of breast cancer, with gene-based assays shedding further light on tumor behavior and response to treatment. ...RESULTS: Clinical studies of the prognostic value of gene-ba …
The discovery of different intrinsic subtypes of breast cancer has advanced the understanding of breast cancer, with gene-base …
Breast cancer in adolescents and young adults.
Johnson RH, Anders CK, Litton JK, Ruddy KJ, Bleyer A. Johnson RH, et al. Pediatr Blood Cancer. 2018 Dec;65(12):e27397. doi: 10.1002/pbc.27397. Epub 2018 Aug 28. Pediatr Blood Cancer. 2018. PMID: 30156052 Free PMC article. Review.
Breast cancer is the most common cancer of adolescents and young adult (AYA) women aged 15 to 39 years, accounting for 5.6% of all invasive breast cancer in women. In comparison with older women, AYAs are more likely to have familial cancer predisposition genes, lar
Breast cancer is the most common cancer of adolescents and young adult (AYA) women aged 15 to 39 years, accounting for 5.6% of all in
Histological type and typing of breast carcinomas and the WHO classification changes over time.
Cserni G. Cserni G. Pathologica. 2020 Mar;112(1):25-41. doi: 10.32074/1591-951X-1-20. Pathologica. 2020. PMID: 32202537 Free PMC article. Review.
The World Health Organization's new classification of breast tumors has just been published. This review aims to examine the morphological categorization of breast carcinomas which is still principally based on histological features and follows the traditions of his …
The World Health Organization's new classification of breast tumors has just been published. This review aims to examine the morpholo …
Screening for breast cancer.
Peairs KS, Choi Y, Stewart RW, Sateia HF. Peairs KS, et al. Semin Oncol. 2017 Feb;44(1):60-72. doi: 10.1053/j.seminoncol.2017.02.004. Epub 2017 Feb 13. Semin Oncol. 2017. PMID: 28395765 Review.
This review will give a general overview of the impact of breast cancer, as well as breast cancer risk factors, identification of high-risk groups, screening modalities, and guidelines for screening average-risk and high-risk individuals, including a case discussion …
This review will give a general overview of the impact of breast cancer, as well as breast cancer risk factors, identification …
Breast fibroadenomas: a review in the light of current literature.
Salati SA. Salati SA. Pol Przegl Chir. 2020 Dec 7;93(1):40-48. doi: 10.5604/01.3001.0014.5676. Pol Przegl Chir. 2020. PMID: 33729177 Free article. Review.
<br><b>Introduction:</b> Fibroadenomas are one of the most common benign tumors of the breast in the adolescent females accounting for about 2/3&lt;sup&gt;rd&lt;/sup&gt; of all the breast lumps and more than …
<br><b>Introduction:</b> Fibroadenomas are one of the most common benign tumors of the breast
Menopausal hormone therapy and breast cancer risk.
Rozenberg S, Di Pietrantonio V, Vandromme J, Gilles C. Rozenberg S, et al. Best Pract Res Clin Endocrinol Metab. 2021 Dec;35(6):101577. doi: 10.1016/j.beem.2021.101577. Epub 2021 Sep 10. Best Pract Res Clin Endocrinol Metab. 2021. PMID: 34535397 Review.
These women should be treated with MHT until the age of 50, as the risk of breast cancer is equal to that of normally menstruating women. Carriers of BRCA 1 & 2 mutation after risk-reducing bilateral salpingo-oophorectomy (RRSO), without a personal history of cancer, h …
These women should be treated with MHT until the age of 50, as the risk of breast cancer is equal to that of normally menstruating wo …
Invasive lobular breast cancer: A review of pathogenesis, diagnosis, management, and future directions of early stage disease.
Thomas M, Kelly ED, Abraham J, Kruse M. Thomas M, et al. Semin Oncol. 2019 Apr;46(2):121-132. doi: 10.1053/j.seminoncol.2019.03.002. Epub 2019 Jun 17. Semin Oncol. 2019. PMID: 31239068 Review.
Invasive lobular carcinoma (ILC) is the second most common type of invasive breast cancer after invasive ductal carcinoma (IDC). Invasive lobular carcinoma has unique clinical, pathologic, and radiographic features which suggest that it is a distinct clinical entity; howev …
Invasive lobular carcinoma (ILC) is the second most common type of invasive breast cancer after invasive ductal carcinoma (IDC). Inva …
Breast cancer: a review for the general surgeon.
Matsen CB, Neumayer LA. Matsen CB, et al. JAMA Surg. 2013 Oct;148(10):971-9. doi: 10.1001/jamasurg.2013.3393. JAMA Surg. 2013. PMID: 23986370 Review.
Breast cancer care is complex and requires a multidisciplinary approach. In this study, we provide an overview of current practices for the diagnosis and treatment of breast cancer for surgical practitioners who do not focus on this disease. ...
Breast cancer care is complex and requires a multidisciplinary approach. In this study, we provide an overview of current practices f
Rethinking breast cancer follow-up based on individual risk and recurrence management.
De Rose F, Meduri B, De Santis MC, Ferro A, Marino L, Colciago RR, Gregucci F, Vanoni V, Apolone G, Di Cosimo S, Delaloge S, Cortes J, Curigliano G. De Rose F, et al. Cancer Treat Rev. 2022 Sep;109:102434. doi: 10.1016/j.ctrv.2022.102434. Epub 2022 Jul 1. Cancer Treat Rev. 2022. PMID: 35933845 Free article. Review.
Current follow-up policies for early breast cancer aim to detect loco-regional recurrences and manage treatment-related adverse effects. ...This change in perspective would transform breast cancer follow-up into an integrated, multidisciplinary team medical practice …
Current follow-up policies for early breast cancer aim to detect loco-regional recurrences and manage treatment-related adverse effec …
50,735 results
You have reached the last available page of results. Please see the User Guide for more information.